Karolinska Seeks New Investments In Portfolio Shakeup Aftermath
This article was originally published in Clinica
Executive Summary
Following the recent re-alignment of its portfolio, Sweden-based technology incubator and investor Karolinska Development is now looking to put more money into additional medtech companies that are close to commercialization or already generating early revenue.